Developer docs
API playgroundTry for free, no card

Search company profiles

U.S. Renal Care

Full company profile

uuid00021oy

Namestring
U.S. Renal Care
Legal namestring
U.S. Renal Care, Inc.
Websiteurl
usrenalcare.com
Company typeenum
Private
Founded yearint
2000
Descriptiontext

U.S. Renal Care is a privately held, PE-owned dialysis service provider founded in 2000 and headquartered in Plano, Texas. The company operates more than 400 outpatient dialysis clinics across 32 states and Guam, serving more than 36,000 patients with end-stage renal disease (ESRD). It is the largest privately held dialysis provider in the United States and the third-largest overall behind DaVita and Fresenius.

The company's core service portfolio comprises in-center hemodialysis, home hemodialysis, peritoneal dialysis, conservative care management, and kidney transplant support. Distribution is multi-channel: directly operated freestanding outpatient clinics are supplemented by home therapy programs, joint ventures with hospital systems (e.g., Pottstown Memorial Medical Center, Mercy Medical Center), shared-ownership partnerships (Liberty Administrative Services in Dallas), and acute care hospital contracts. Technology integration is selectively pursued through partnerships, including Vexev's VxWave robotic ultrasound vascular mapping system and adoption of VAFSEO therapy, alongside an Office of Disaster Management coordinating emergency response across federal, state, and local partners.

U.S. Renal Care generates revenue by billing Medicare, Medicaid, and private insurance for dialysis treatments under the CMS bundled ESRD reimbursement framework. The business is enterprise field sales-led, with patient acquisition driven by nephrologist referral partnerships and hospital joint ventures across 32 states. The company was acquired by an investor group in March 2019, and Mark Caputo (founder of Liberty Dialysis) has served as Chairman and CEO since June 2020. The executive bench is heavily staffed by veterans of DaVita, Fresenius, and Satellite Healthcare, and USRC reports the highest percentage of CMS 4- and 5-star rated centers for patient experience and quality of care among dialysis providers.

Short descriptiontext

U.S. Renal Care is the largest privately held U.S. dialysis provider, operating 400+ outpatient clinics across 32 states and Guam to deliver in-center and home hemodialysis, peritoneal dialysis, and kidney care support to more than 36,000 ESRD patients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersPlano, United States
HQ citystring
Plano
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
dialysis services, kidney care, hemodialysis treatment, peritoneal dialysis, renal healthcare
Industry6 codes
1Outpatient Dialysis & Kidney Care Centers
CodeHLAFABAEPrimaryYes
2Dialysis Services (Hemodialysis & Peritoneal Dialysis)
CodeHLAKAHACPrimaryNo
3General Nephrology Practice
CodeHLAKAHAAPrimaryNo
4Home Dialysis Support & Training Providers
CodeHLAFAEAGPrimaryNo
5Home Dialysis Equipment & Remote Monitoring
CodeHLAHAKAGPrimaryNo
6Kidney & Dialysis Remote Care (CKD/ESRD monitoring, home dialysis support)
CodeHLALAFACPrimaryNo
NAICS code4 codes
  • Kidney Dialysis Centers621492
  • Ambulatory Health Care Services621
  • Home Health Care Services621610
  • Other Ambulatory Health Care Services6219
SIC code3 codes
  • Services-Specialty Outpatient Facilities, Nec8093
  • Services-Home Health Care Services8082
  • Services-Health Services8000
Product category
Dialysis Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Dialysis Treatment Services
TypeSubscription Recurring
Description

U.S. Renal Care generates revenue through providing dialysis treatment services billed to Medicare, Medicaid, and private insurance providers for patients with end-stage renal disease.

usrenalcare.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

U.S. Renal Care operates a national network of outpatient dialysis clinics providing in-center hemodialysis, home hemodialysis, peritoneal dialysis, conservative care management, and kidney transplant support services to patients with end-stage renal disease. The company serves more than 36,000 patients through over 400 clinics across 32 states and Guam, partnering with nephrologists and hospital systems to deliver kidney care.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Highest percentage of CMS 4- and 5-star rated centers for patient experience and quality of care in the dialysis industry
Product overview1 text field

U.S. Renal Care is a dialysis service provider offering a unified portfolio of kidney care services. The core offering consists of in-center hemodialysis, home hemodialysis, and peritoneal dialysis as the primary treatment modalities, supplemented by conservative care management for patients not pursuing dialysis and kidney transplant support services to help patients navigate the transplant process. The company operates outpatient dialysis facilities across 32 states, providing comprehensive kidney disease management throughout the patient care journey.

Product and service2 records
1In-Center Hemodialysis
CategoryIn-Center Dialysis
Description

Outpatient hemodialysis treatment delivered at U.S. Renal Care's freestanding dialysis clinics where patients receive supervised treatments multiple times per week from clinical staff.

2Home Hemodialysis
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2026-03-02
Description

U.S. Renal Care was a sponsor of the American Kidney Fund's seventh annual Kidney Action Week (March 2-5, 2026), a free virtual conference bringing together kidney disease patients, health professionals, caregivers, and advocates.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-11-10
Description

Vexev conducted a clinical trial of its VxWave Ultrasound Imaging System at U.S. Renal Care dialysis clinics, demonstrating high success and data adequacy rates for vascular mapping in dialysis patients. The trial involved 115 patients and showed the system's potential to standardize vascular assessment at point of care.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-10-22
Description

U.S. Renal Care and Satellite Healthcare jointly announced 20 nephrology nurses honored with the DAISY Award during Nephrology Nurses Week. The organizations also collaborate on nurse recognition and education programs.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2020-07-01
Description

Mercy Medical Center partnered with U.S. Renal Care to expand dialysis services, with U.S. Renal Care providing dialysis care and management services at the hospital.

5Liberty Administrative Services / Dallas Renal Group
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2016-02-11
Description

U.S. Renal Care partnered with Liberty Administrative Services to share ownership and management of nine clinics in the Dallas area, serving more than 500 patients.

usrenalcare.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2013-05-23
Description

U.S. Renal Care formed a joint venture with Pottstown Memorial Medical Center, acquiring a controlling interest in the existing hospital dialysis clinic and a previously operated USRC clinic.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

U.S. Renal Care supports National Kidney Foundation initiatives including the annual Caring for Kidneys 5K Run/Walk and general kidney disease awareness programs.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

U.S. Renal Care co-founded the Nephrology Business Leadership Conference (NBLU) in collaboration with Dallas Renal Group and UC San Diego in 2016, providing business education for nephrology fellows.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Largest U.S. dialysis provider operating thousands of in-center and home dialysis clinics. Directly competes with USRC for nephrologist partnerships, hospital joint ventures, and ESRD patients across overlapping geographies.

TypeDirect peer
Description

Second-largest U.S. dialysis provider and global dialysis leader, offering the same in-center hemodialysis, peritoneal dialysis, and home hemodialysis modalities as USRC, plus vertically integrated dialyzer and device manufacturing.

TypeDirect peer
Description

Nonprofit dialysis provider operating in-center and home dialysis programs; partner with USRC on nurse recognition programs (DAISY Award) and overlapping clinical leadership talent. Competes for nephrologist partnerships in California and adjacent markets.

TypeDirect peer
Description

Specialized dialysis provider focused on geriatric and SNF-based hemodialysis, addressing the same ESRD population USRC serves. Competes for hospital-system and skilled-nursing-facility contracts in overlapping geographies.

TypeDirect peer
Description

Specialty dialysis provider concentrating on skilled nursing facilities and acute-care settings. Targets the same ESRD patient population through hospital and SNF partnerships that overlap with USRC's distribution strategy.

TypeDirect peer
Description

Nonprofit dialysis provider operating in-center, home, and acute dialysis programs nationwide. Competes with USRC for nephrologist relationships and patient referrals across multiple states.

TypeDirect peer
Description

Mid-sized dialysis operator offering in-center and home dialysis; emerged from the American Renal Associates platform and competes directly with USRC in regional markets for nephrologist partnerships and patient share.

TypeEmerging player
Description

Value-based kidney care company partnering with nephrologists and payors to manage CKD and ESRD populations upstream of dialysis. Represents a structural threat and adjacent model to USRC's traditional in-center dialysis business.

TypeEmerging player
Description

Value-based kidney care organization formed via Fresenius/Cricket Health/InterWell merger, taking global risk for CKD and ESRD patients. Competes with USRC for risk-bearing relationships with payors and nephrologists.

TypeEmerging player
Description

In-home kidney and chronic condition care provider serving CKD/ESRD patients with multidisciplinary teams. Operates adjacent to dialysis delivery by managing upstream CKD and competing for payor risk arrangements.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds18 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

U.S. Renal Care

Dialysis Servicesusrenalcare.com

U.S. Renal Care is the largest privately held U.S. dialysis provider, operating 400+ outpatient clinics across 32 states and Guam to deliver in-center and home hemodialysis, peritoneal dialysis, and kidney care support to more than 36,000 ESRD patients.

What U.S. Renal Care does

U.S. Renal Care is a privately held, PE-owned dialysis service provider founded in 2000 and headquartered in Plano, Texas. The company operates more than 400 outpatient dialysis clinics across 32 states and Guam, serving more than 36,000 patients with end-stage renal disease (ESRD). It is the largest privately held dialysis provider in the United States and the third-largest overall behind DaVita and Fresenius.

The company's core service portfolio comprises in-center hemodialysis, home hemodialysis, peritoneal dialysis, conservative care management, and kidney transplant support. Distribution is multi-channel: directly operated freestanding outpatient clinics are supplemented by home therapy programs, joint ventures with hospital systems (e.g., Pottstown Memorial Medical Center, Mercy Medical Center), shared-ownership partnerships (Liberty Administrative Services in Dallas), and acute care hospital contracts. Technology integration is selectively pursued through partnerships, including Vexev's VxWave robotic ultrasound vascular mapping system and adoption of VAFSEO therapy, alongside an Office of Disaster Management coordinating emergency response across federal, state, and local partners.

U.S. Renal Care generates revenue by billing Medicare, Medicaid, and private insurance for dialysis treatments under the CMS bundled ESRD reimbursement framework. The business is enterprise field sales-led, with patient acquisition driven by nephrologist referral partnerships and hospital joint ventures across 32 states. The company was acquired by an investor group in March 2019, and Mark Caputo (founder of Liberty Dialysis) has served as Chairman and CEO since June 2020. The executive bench is heavily staffed by veterans of DaVita, Fresenius, and Satellite Healthcare, and USRC reports the highest percentage of CMS 4- and 5-star rated centers for patient experience and quality of care among dialysis providers.

U.S. Renal Care firmographics

Firmographics
Name
U.S. Renal Care
Legal name
U.S. Renal Care, Inc.
Website
https://usrenalcare.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
U.S. Renal Care is the largest privately held U.S. dialysis provider, operating 400+ outpatient clinics across 32 states and Guam to deliver in-center and home hemodialysis, peritoneal dialysis, and kidney care support to more than 36,000 ESRD patients.
Ownership category
akta.pro rank

U.S. Renal Care industry classification

Industry
Product category
Dialysis Services
NAICS
Kidney Dialysis Centers (621492), Ambulatory Health Care Services (621), Home Health Care Services (621610), Other Ambulatory Health Care Services (6219)
SIC
Services-Specialty Outpatient Facilities, Nec (8093), Services-Home Health Care Services (8082), Services-Health Services (8000)
akta.pro primary industry
Outpatient Dialysis & Kidney Care Centers (HLAFABAE)
akta.pro secondary industries
Dialysis Services (Hemodialysis & Peritoneal Dialysis) (HLAKAHAC), General Nephrology Practice (HLAKAHAA), Home Dialysis Support & Training Providers (HLAFAEAG), Home Dialysis Equipment & Remote Monitoring (HLAHAKAG), Kidney & Dialysis Remote Care (CKD/ESRD monitoring, home dialysis support) (HLALAFAC)

Keywords

  • Dialysis services
  • Kidney care
  • Hemodialysis treatment
  • Peritoneal dialysis
  • Renal healthcare

Where U.S. Renal Care is headquartered

Location

Headquarters

HQ city
Plano
HQ country
United States
HQ region
North America

Offices2 records

Markets served

U.S. Renal Care business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

  1. Dialysis Treatment Services: U.S. Renal Care generates revenue through providing dialysis treatment services billed to Medicare, Medicaid, and private insurance providers for patients with end-stage renal disease.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

U.S. Renal Care product offering

Product offering

Core offering

U.S. Renal Care operates a national network of outpatient dialysis clinics providing in-center hemodialysis, home hemodialysis, peritoneal dialysis, conservative care management, and kidney transplant support services to patients with end-stage renal disease. The company serves more than 36,000 patients through over 400 clinics across 32 states and Guam, partnering with nephrologists and hospital systems to deliver kidney care.

Product overview

U.S. Renal Care is a dialysis service provider offering a unified portfolio of kidney care services. The core offering consists of in-center hemodialysis, home hemodialysis, and peritoneal dialysis as the primary treatment modalities, supplemented by conservative care management for patients not pursuing dialysis and kidney transplant support services to help patients navigate the transplant process. The company operates outpatient dialysis facilities across 32 states, providing comprehensive kidney disease management throughout the patient care journey.

Differentiator

Problem solved

Functional benefit

Products and services

  • In-Center Hemodialysis Outpatient hemodialysis treatment delivered at U.S. Renal Care's freestanding dialysis clinics where patients receive supervised treatments multiple times per week from clinical staff.
  • Home Hemodialysis

Quantifiable outcome

  • Highest percentage of CMS 4- and 5-star rated centers for patient experience and quality of care in the dialysis industry

Companies that use U.S. Renal Care

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

U.S. Renal Care technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

U.S. Renal Care partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered minor.

  • American Kidney FundminorGTM or Marketing Partner · 2 March 2026U.S. Renal Care was a sponsor of the American Kidney Fund's seventh annual Kidney Action Week (March 2-5, 2026), a free virtual conference bringing together kidney disease patients, health professionals, caregivers, and advocates.
  • VexevminorStrategic or Co-development Partner · 10 November 2025Vexev conducted a clinical trial of its VxWave Ultrasound Imaging System at U.S. Renal Care dialysis clinics, demonstrating high success and data adequacy rates for vascular mapping in dialysis patients. The trial involved 115 patients and showed the system's potential to standardize vascular assessment at point of care.
  • Satellite HealthcareminorStrategic or Co-development Partner · 22 October 2025U.S. Renal Care and Satellite Healthcare jointly announced 20 nephrology nurses honored with the DAISY Award during Nephrology Nurses Week. The organizations also collaborate on nurse recognition and education programs.
  • Mercy Medical CenterminorStrategic or Co-development Partner · 1 July 2020Mercy Medical Center partnered with U.S. Renal Care to expand dialysis services, with U.S. Renal Care providing dialysis care and management services at the hospital.
  • Liberty Administrative Services / Dallas Renal GroupminorStrategic or Co-development Partner · 11 February 2016U.S. Renal Care partnered with Liberty Administrative Services to share ownership and management of nine clinics in the Dallas area, serving more than 500 patients.
  • Pottstown Memorial Medical CenterminorStrategic or Co-development Partner · 23 May 2013U.S. Renal Care formed a joint venture with Pottstown Memorial Medical Center, acquiring a controlling interest in the existing hospital dialysis clinic and a previously operated USRC clinic.
  • National Kidney FoundationminorStrategic or Co-development PartnerU.S. Renal Care supports National Kidney Foundation initiatives including the annual Caring for Kidneys 5K Run/Walk and general kidney disease awareness programs.
  • University of California San DiegominorStrategic or Co-development PartnerU.S. Renal Care co-founded the Nephrology Business Leadership Conference (NBLU) in collaboration with Dallas Renal Group and UC San Diego in 2016, providing business education for nephrology fellows.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

U.S. Renal Care competitors and assessment

Company assessment

Direct peers

  • DaVita Kidney Care: Largest U.S. dialysis provider operating thousands of in-center and home dialysis clinics. Directly competes with USRC for nephrologist partnerships, hospital joint ventures, and ESRD patients across overlapping geographies.
  • Fresenius Medical Care: Second-largest U.S. dialysis provider and global dialysis leader, offering the same in-center hemodialysis, peritoneal dialysis, and home hemodialysis modalities as USRC, plus vertically integrated dialyzer and device manufacturing.
  • Satellite Healthcare: Nonprofit dialysis provider operating in-center and home dialysis programs; partner with USRC on nurse recognition programs (DAISY Award) and overlapping clinical leadership talent. Competes for nephrologist partnerships in California and adjacent markets.
  • Dialyze Direct: Specialized dialysis provider focused on geriatric and SNF-based hemodialysis, addressing the same ESRD population USRC serves. Competes for hospital-system and skilled-nursing-facility contracts in overlapping geographies.
  • Concerto Renal Services: Specialty dialysis provider concentrating on skilled nursing facilities and acute-care settings. Targets the same ESRD patient population through hospital and SNF partnerships that overlap with USRC's distribution strategy.
  • Dialysis Clinic, Inc. (DCI): Nonprofit dialysis provider operating in-center, home, and acute dialysis programs nationwide. Competes with USRC for nephrologist relationships and patient referrals across multiple states.
  • Innovative Renal Care: Mid-sized dialysis operator offering in-center and home dialysis; emerged from the American Renal Associates platform and competes directly with USRC in regional markets for nephrologist partnerships and patient share.

Emerging players

  • Strive Health: Value-based kidney care company partnering with nephrologists and payors to manage CKD and ESRD populations upstream of dialysis. Represents a structural threat and adjacent model to USRC's traditional in-center dialysis business.
  • InterWell Health: Value-based kidney care organization formed via Fresenius/Cricket Health/InterWell merger, taking global risk for CKD and ESRD patients. Competes with USRC for risk-bearing relationships with payors and nephrologists.
  • Monogram Health: In-home kidney and chronic condition care provider serving CKD/ESRD patients with multidisciplinary teams. Operates adjacent to dialysis delivery by managing upstream CKD and competing for payor risk arrangements.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

U.S. Renal Care social profiles

Digital presence

U.S. Renal Care compliance and trust

Trust signal

Compliance1 record

U.S. Renal Care financial estimates

Financial estimate

Revenue estimate

Valuation estimate

U.S. Renal Care leadership team

Management profile

Number of profiles

Profiles14 records

U.S. Renal Care subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

U.S. Renal Care funding detail

Funding detail

Funding overview

Funding rounds18 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

U.S. Renal Care M&A and investment

M&A and investment

M&A4 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about U.S. Renal Care

What does U.S. Renal Care do?

U.S. Renal Care operates a national network of outpatient dialysis clinics providing in-center hemodialysis, home hemodialysis, peritoneal dialysis, conservative care management, and kidney transplant support services to patients with end-stage renal disease. The company serves more than 36,000 patients through over 400 clinics across 32 states and Guam, partnering with nephrologists and hospital systems to deliver kidney care.

Is U.S. Renal Care a public or private company?

U.S. Renal Care is a private company. It is classified as private equity controlled and is currently operating.

When was U.S. Renal Care founded?

U.S. Renal Care was founded in 2000. It employs 1,001 to 5,000 people.

Where is U.S. Renal Care based?

U.S. Renal Care is headquartered in Plano, United States, in the North America region.

How does U.S. Renal Care make money?

One revenue line is on record: dialysis Treatment Services.

Who are U.S. Renal Care's main competitors?

Direct peers on record are DaVita Kidney Care, Fresenius Medical Care, Satellite Healthcare, Dialyze Direct, Concerto Renal Services, Dialysis Clinic, Inc. (DCI) and Innovative Renal Care. Emerging players are Strive Health, InterWell Health and Monogram Health.

Does U.S. Renal Care have an API?

No public API is recorded for U.S. Renal Care.

What industry is U.S. Renal Care in?

U.S. Renal Care's product category is Dialysis Services. Its primary akta.pro industry code is HLAFABAE, Outpatient Dialysis & Kidney Care Centers, with a secondary code of HLAKAHAC, Dialysis Services (Hemodialysis & Peritoneal Dialysis). Its NAICS code is 621492 and its SIC code is 8093.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireU.S. Renal Care & Satellite Healthcare Honor 25 Nurses with National DAISY Award During Nephrology Nurses WeekU.S. Renal Care and Satellite Healthcare honored 25 nurses with the DAISY Award during Nephrology Nurses Week, September 13–19, 2026. The award recognizes exceptional clinical care and compassion, with recipients receiving certificates, pins, and a Healer's Touch sculpture. The company also promotes its Nightingale Program to support nursing career development.Clinical Trials ArenaR1 Therapeutics secures $80.5m to fund Phase IIb AP306 studyR1 Therapeutics expanded its Series A financing to $80.5m to advance AP306 in a Phase IIb trial for hyperphosphatemia in dialysis-dependent chronic kidney disease patients. The round includes Samsara BioCapital and expects top-line results in the first half of 2027.Venture Capital Access OnlineR1 Therapeutics expands Series A to $80.5 million to advance global Phase 2b program in hyperphosphatemiaR1 Therapeutics expanded its Series A financing to $80.5 million, adding Samsara BioCapital to an existing syndicate. The funds will advance AP306, a pan phosphate transporter inhibitor in a global Phase 2b trial for hyperphosphatemia in dialysis patients, with topline data expected in H1 2027.BioSpaceR1 Therapeutics expands Series A to $80.5 million to advance global Phase 2b program in hyperphosphatemiaR1 Therapeutics expanded its Series A financing to $80.5 million, adding Samsara BioCapital to an existing syndicate. The funds will advance AP306, a pan phosphate transporter inhibitor in a global Phase 2b trial for hyperphosphatemia in dialysis patients, with topline data expected in H1 2027.PR NewswireU.S. Renal Care Premieres Short Film About One Runner's Race for Kidney Disease AwarenessU.S. Renal Care premiered a short film titled "Run, DJ, Run" documenting Dwaine "DJ" Haskins Jr.'s journey running the 2025 New York City Marathon to raise awareness for kidney disease in honor of his uncle David Rush, a dialysis patient and employee at the company. The film, featuring both Haskins and Rush, aims to highlight how kidney disease affects patients and their families while showcasing the company's mission and patient care outreach. The premiere was conducted as part of U.S. Renal Care's awareness and community engagement efforts around kidney disease, which impacts millions of Americans.OctusU.S. Renal Care Working With Barclays for Potential HY Bond Deal to Refinance DebtU.S. Renal Care is working with Barclays on a potential high-yield bond deal to refinance its existing debt, including 10.625% first lien 2028 notes and its 2028 term loan B. The company's first-quarter 2026 adjusted EBITDA rose 10.5% year over year to $63 million, though total debt stands at $1.96 billion with gross leverage of 7x. The proposed refinancing would consolidate debt from a 2023 uptier transaction that carved out an unrestricted subsidiary, with an investor expecting the deal to fold separate entities back into a single consolidated structure.GlobeNewswireU.S. Renal Care and Akebia Announce Interim Analysis of VOICE Trial Demonstrated Overwhelming Statistical Evidence of Improved Safety Outcomes for Patients Treated with Vafseo versus an ESAAkebia and U.S. Renal Care stopped the VOICE trial after interim analysis showed Vafseo significantly reduced the composite endpoint of mortality and hospitalization versus an ESA. The trial enrolled 2,116 patients and met stopping criteria with a win odds of 1.16, driven by fewer hospitalizations. Results will be submitted to an upcoming scientific meeting.PR NewswireU.S. Renal Care Associate Chief Medical Officer Geoffrey A. Block, MD, FASN Awarded 2026 AAKP Medal of Excellence for Lifetime Contributions to Kidney CareU.S. Renal Care Associate Chief Medical Officer Geoffrey A. Block, MD, FASN has been awarded the 2026 American Association of Kidney Patients (AAKP) Medal of Excellence, one of the organization's highest honors for kidney healthcare professionals. Dr. Block has authored or contributed to more than 140 peer-reviewed studies and played pivotal roles in landmark clinical trials for therapies including Cinacalcet, Parsabiv®, Tenapanor, and VAFSEO, spanning a career of more than three decades. He continues to lead industry-wide efforts at U.S. Renal Care to accelerate adoption of innovative therapies for end-stage kidney disease.AijournKidneylink Leads the Industry as #1 in Value-Based Kidney Care SavingsKidneylink, a national value-based kidney care organization founded by U.S. Renal Care, has been recognized as the top performer in the CMS 2024 Kidney Care Choices Model, achieving the highest net and gross savings among all 80 Kidney Care Entities. The company delivered 6.4% gross savings versus a 4.8% program average and 2.6% net savings versus a 1.9% benchmark, while 60% of its KCEs earned CMS distinction for highest performance in quality metrics including CKD progression delay, mortality reduction, and transplant outcomes. Founded in 2021, Kidneylink partners with over 400 nephrologists to care for 15,000 patients across its 10 participating Kidney Care Entities.PR NewswireKidneylink Leads the Industry as #1 in Value-Based Kidney Care SavingsKidneylink, a national value-based kidney care organization founded by U.S. Renal Care, achieved the #1 ranking in the 2024 Kidney Care Choices Model results released by CMMI, delivering the highest reduction in total medical costs and highest performance in quality metrics among all 80 participating Kidney Care Entities. The company posted Gross Savings of 6.4% versus a 4.8% program average and Net Savings of 2.6% versus a 1.9% benchmark, outperforming large dialysis organizations including Fresenius/Interwell and DaVita. Looking ahead, Kidneylink expects 2025 and 2026 results to significantly improve as it expands through partnerships with private payors beyond its original CMS CKCC program.